Patents by Inventor Takanori Oka
Takanori Oka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11967233Abstract: To provide a vehicle sharing system that allows the user to use a shared vehicle having a battery with a reduced risk of the battery running out, a management server (1) includes a management information database (122) configured to store information on (i) a plurality of shared-vehicle standby locations (2) at each of which a motor-assisted bicycle(s) (3) having a battery (302) is on standby, (ii) a motor-assisted bicycle(s) (3), and (iii) the destination desired by the user; and a location specifying section (115) configured to, in a case where the location specifying section (115) has determined that the remaining battery power of the motor-assisted bicycle (3) that the user is using is not enough to continue to travel to the destination desired by the user, specify a transfer location.Type: GrantFiled: September 25, 2017Date of Patent: April 23, 2024Assignee: Omron CorporationInventors: Hideaki Kojima, Masashi Sato, Takanori Oka
-
Publication number: 20210287540Abstract: To provide a vehicle sharing system that allows the user to use a shared vehicle having a battery with a reduced risk of the battery running out, a management server (1) includes a management information database (122) configured to store information on (i) a plurality of shared-vehicle standby locations (2) at each of which a motor-assisted bicycle(s) (3) having a battery (302) is on standby, (ii) a motor-assisted bicycle(s) (3), and (iii) the destination desired by the user; and a location specifying section (115) configured to, in a case where the location specifying section (115) has determined that the remaining battery power of the motor-assisted bicycle (3) that the user is using is not enough to continue to travel to the destination desired by the user, specify a transfer location.Type: ApplicationFiled: September 25, 2017Publication date: September 16, 2021Applicant: Omron CorporationInventors: Hideaki Kojima, Masashi Sato, Takanori Oka
-
Publication number: 20190228466Abstract: To provide a vehicle sharing system that (i) prevents a particular vehicle location among a plurality of vehicle locations at each of which a shared vehicle(s) is on standby from being used excessively and thereby (ii) improves the convenience of the user, a management server (1) includes a management information database (122) configured to store information on (i) a plurality of shared-vehicle standby locations (2) at each of which a motor-assisted bicycle(s) (3) having a battery (302) is on standby and (ii) a motor-assisted bicycle(s) (3); a communication section (103) configured to receive starting-place information and destination information from a portable terminal (4); and a location specifying section (115) configured to, with reference to the management information database (122), specify a shared-vehicle standby location (2) to be used by the user to rent out a shared vehicle.Type: ApplicationFiled: September 25, 2017Publication date: July 25, 2019Applicant: Omron CorporationInventors: Hideaki Kojima, Masashi Sato, Takanori Oka
-
Patent number: 9261285Abstract: An air conditioner has: a casing 20 having an air inlet 21 and an air outlet 22; a heater 53 disposed in the casing 20 and heating air having flowed through the air inlet 21 into the casing 20; holders 54 and 55 holding the heater 53 and fitted to the casing 20; and a spacer 59 in contact with the heater 53 and disposed between the holders 54 and 55 and the heater 53. At least one of the heat-resistance and the flame-retardance of the spacer 59 is higher than that of the holders 54 and 55.Type: GrantFiled: October 19, 2009Date of Patent: February 16, 2016Assignee: SHARP KABUSHIKI KAISHAInventors: Michio Setsu, Takanori Oka, Hirokazu Uemae, Keisuke Uchida
-
Publication number: 20150203931Abstract: The first purpose of the present invention is to provide a method for producing metallic iron, whereby, in the production of metallic iron by heating an agglomerate, which comprises an iron oxide-containing material and a carbonaceous reductant, in a movable hearth type heating furnace, metallic iron can be efficiently collected from a reduced product containing metallic iron and a slag, said reduced product being obtained by heating the agglomerate.Type: ApplicationFiled: August 5, 2013Publication date: July 23, 2015Applicant: KABUSHIKI KAISHA KOBE SEIKO SHO (KOBE STEEL, LTD.)Inventors: Takeshi Sugiyama, Takao Harada, Junichi Shiino, Tsuyoshi Mimura, Katsuyuki Iijima, Takanori Oka
-
Patent number: 9079961Abstract: An object of the present invention is to provide a probe, primer, primer set and antibody for determining neonatal alloimmune thrombocytopenic purpura or the risk of developing it. According to the present invention, there is provided a probe, primer, primer set and antibody for use in the detection of the thymine residue at position 1297 in the GPIIIa.Type: GrantFiled: May 26, 2008Date of Patent: July 14, 2015Assignees: JAPANESE RED CROSS SOCIETY, WAKUNAGA PHARMACEUTICAL CO., LTD.Inventors: Atsuko Taniue, Hiroyuki Ishii, Shinji Maekawajiri, Nozomi Nagata, Takanori Oka
-
Publication number: 20130335194Abstract: A key managed by a key management device has an operation detecting unit configured to detect an operating state thereof, and a transmitter configured to transmit information of the operating state detected by the operation detecting unit to receiving devices through wireless communication. The operation detecting unit includes an acceleration sensor, and detects information of acceleration measured by the acceleration sensor as the operating state thereof.Type: ApplicationFiled: January 5, 2012Publication date: December 19, 2013Applicant: OMRON CORPORATIONInventors: Ryoji Shimizu, Masashi Sato, Hiroaki Takeya, Takanori Oka, Mitsunori Sugiura
-
Patent number: 8206902Abstract: A primer set that allows a target nucleic acid to be amplified specifically and efficiently. The primer set of the present invention includes at least two primers that allow a target nucleic acid sequence to be amplified. A first primer included in the primer set contains, in its 3? end portion, a sequence (Ac?) that hybridizes to a sequence (A) located in the 3? end portion of the target nucleic acid sequence. The first primer also contains, on the 5? side of the sequence (Ac?), a sequence (B?) that hybridizes to a complementary sequence (Bc) to a sequence (B) that is present on the 5? side with respect to the sequence (A) in the target nucleic acid sequence. A second primer included in the primer set contains, in its 3? end portion, a sequence (Cc?) that hybridizes to a sequence (C) located in the 3? end portion of a complementary sequence to the target nucleic acid sequence.Type: GrantFiled: December 24, 2004Date of Patent: June 26, 2012Assignees: Riken, Kabushiki Kaisha DnaformInventors: Yasumasa Mitani, Takanori Oka, Yoshihide Hayashizaki, Toshizo Hayashi
-
Publication number: 20110214443Abstract: An air conditioner includes: an air passage 23 that is formed in a cabinet 20 so as to connect a suction port 21 and a blowoff port 22 to each other, which are open on a surface of the cabinet 20; a blower fan 25 that is disposed inside the air passage 23 so as to extend in one direction; a heat exchanger 27 that is disposed so as to be opposed to the suction port 21 and cools air flowing in through the suction port 21; a heater 28a that is disposed between the blower fan 25 and the heat exchanger 27 in order to heat air flowing in through the suction port 21 and is shorter in a longitudinal direction than the blower fan 25; a control element 52 that controls the heater 28a and is disposed outside the air passage 23 adjacently to the air passage 23; and a heat sink 70 that is in close contact with the control element 52 and is disposed between the blower fan 25 and the heat exchanger 27, on an outside of the heater 28a in the longitudinal direction.Type: ApplicationFiled: March 2, 2011Publication date: September 8, 2011Inventors: Takanori OKA, Toshio Tashima, Hirokazu Uemae, Keisuke Uchida, Yohhei Takasaki
-
Publication number: 20110000251Abstract: According to the present invention, there is provided an air conditioner which is capable of, even when the direction of wind blown out from a blow-out port is greatly changed, efficiently releasing ions to a distant place. Specifically, the air conditioner according to the present invention is configured by including a wind direction changing plate 800 which changes the direction of wind W0 blown out from a blow-out port 5, an ion generating section 921a which is provided in the wind direction changing plate 800, and a guiding section 891 which, when the wind direction changing plate 800 is held in an inclined attitude oriented at an angle with respect to the blow-out direction of the wind, protects the ion generating section 921a by preventing the wind W0 blown out from the blow-out port 5 from being brought into direct contact with the ion generating section 921a, and which guides the wind flowing along the wind direction changing plate 800 into the ion generating section 921a.Type: ApplicationFiled: April 15, 2009Publication date: January 6, 2011Inventors: Takanori Oka, Yuichi Rokkaku
-
Publication number: 20100212861Abstract: An air conditioner has: a casing 20 having an air inlet 21 and an air outlet 22; a heater 53 disposed in the casing 20 and heating air having flowed through the air inlet 21 into the casing 20; holders 54 and 55 holding the heater 53 and fitted to the casing 20; and a spacer 59 in contact with the heater 53 and disposed between the holders 54 and 55 and the heater 53. At least one of the heat-resistance and the flame-retardance of the spacer 59 is higher than that of the holders 54 and 55.Type: ApplicationFiled: October 19, 2009Publication date: August 26, 2010Inventors: Michio SETSU, Takanori OKA, Hirokazu UEMAE, Keisuke UCHIDA
-
Publication number: 20100173292Abstract: An object of the present invention is to provide a probe, primer, primer set and antibody for determining neonatal alloimmune thrombocytopenic purpura or the risk of developing it. According to the present invention, there is provided a probe, primer, primer set and antibody for use in the detection of the thymine residue at position 1297 in the GPIIIa.Type: ApplicationFiled: May 26, 2008Publication date: July 8, 2010Inventors: Atsuko Taniue, Hiroyuki Ishii, Shinji Maekawajiri, Nozomi Nagata, Takanori Oka
-
Publication number: 20080311571Abstract: A nucleic acid fragment set according to the present invention comprises a plural number of nucleic acid fragments capable of individually hybridizing with a plural number of target sequences, in which each nucleic acid fragment has a region ligatable with each other and the affinity between such ligatable regions is adjusted to a higher level than the affinity between the target sequence and the nucleic acid fragment. The nucleic acid fragment according to the present invention is for use in a nucleic acid fragment kit. The nucleic acid fragment of the present invention can be used as a probe for detecting nucleic acid or a competitor for detecting nucleic acid. According to the present invention, human leukocyte antigen (HLA) genes, T-cell receptor genes, red blood cell group determining genes, and Rh antigen genes, and the like can be detected at a high accuracy level.Type: ApplicationFiled: November 21, 2005Publication date: December 18, 2008Applicant: WAKUNAGA PHARMACEUTICAL CO., LTD.Inventors: Hiroshi Jikihara, Shintaro Kawai, Takanori Oka
-
Publication number: 20070190531Abstract: A primer set that allows a target nucleic acid to be amplified specifically and efficiently. The primer set of the present invention includes at least two primers that allow a target nucleic acid sequence to be amplified. A first primer included in the primer set contains, in its 3? end portion, a sequence (Ac?) that hybridizes to a sequence (A) located in the 3? end portion of the target nucleic acid sequence. The first primer also contains, on the 5? side of the sequence (Ac?), a sequence (B?) that hybridizes to a complementary sequence (Bc) to a sequence (B) that is present on the 5? side with respect to the sequence (A) in the target nucleic acid sequence. A second primer included in the primer set contains, in its 3? end portion, a sequence (Cc?) that hybridizes to a sequence (C) located in the 3? end portion of a complementary sequence to the target nucleic acid sequence.Type: ApplicationFiled: December 24, 2004Publication date: August 16, 2007Applicants: Riken, Kabushiki Kaisha DnaformInventors: Yasumasa Mitani, Takanori Oka, Yoshihide Hayashizaki, Toshizo Hayashi
-
Publication number: 20060194207Abstract: The present invention provides a reactor for carrying out in a single container the steps of the extraction of nucleic acids and the amplification of a nucleic acid, the procedures of the steps being usually different to each other. The reactor according to the present invention is a reactor for detecting a target nucleic acid from a sample, comprising at least a first compartment which contains an extraction reagent composition for extracting nucleic acids from said sample, a second compartment which contains an amplification reagent composition for amplifying the target nucleic acid, a separating means for separating the first and second compartments, and an aperture which enables to introduce said sample into only said first compartment.Type: ApplicationFiled: July 29, 2004Publication date: August 31, 2006Applicants: Riken, Kabushiki Kaisha Danform, Wakunaga Pharmaceutical Co., Ltd.Inventors: Yasumasa Mitani, Takanori Oka, Yoshihide Hayashizaki, Toshizo Hayashi
-
Patent number: 6306603Abstract: The present invention provides CD36 mutant gene and methods and kits for diagnosing diseases caused by a lipid metabolism abnormality.Type: GrantFiled: January 3, 2000Date of Patent: October 23, 2001Assignee: Wakunaga Phaemaceutical Co., Ltd.Inventors: Takanori Oka, Akio Yamane, Takao Tanaka
-
Patent number: 6288035Abstract: A tumor associated protein has been discovered to exhibit immunoreactivity to human monoclonal antibody L92. A ten amino acid peptide segment of the protein and a fourteen amino acid peptide which contains the ten amino acid peptide has also been isolated and exhibits immunoreactivity to the same antibody. Using truncated fusion proteins, the minimum recognition site for antibody binding was determined to be four amino acids. Also disclosed are polypeptide compositions against human tumors that includes the polypeptides or protein of the present disclosure, as well as antibodies reactive with these polypeptides that may be employed directly for treatment or diagnosis. A certain embodiment of the present invention is also the DNA sequence encoding the ten amino acid peptide and the DNA encoding the fourteen amino acid peptide which also exhibits immunoreactivity to human monoclonal antibody L92 and cytotoxic T cells.Type: GrantFiled: February 15, 2000Date of Patent: September 11, 2001Assignee: John Wayne Cancer InstituteInventors: Reiko F. Irie, Takanori Oka
-
Patent number: 6077950Abstract: A tumor associated protein has been discovered to exhibit immunoreactivity to human monoclonal antibody L92. A ten amino acid peptide segment of the protein and a fourteen amino acid peptide which contains the ten amino acid peptide has also been isolated and exhibits immunoreactivity to the same antibody. Using truncated fusion proteins, the minimum recognition site for antibody binding was determined to be four amino acids. Also disclosed are polypeptide compositions against human tumors that includes the polypeptides or protein of the present disclosure, as well as antibodies reactive with these polypeptides that may be employed directly for treatment or diagnosis. A certain embodiment of the present invention is also the DNA sequence encoding the ten amino acid peptide and the DNA encoding the fourteen amino acid peptide which also exhibits immunoreactivity to human monoclonal antibody L92 and cytotoxic T cells.Type: GrantFiled: February 9, 1999Date of Patent: June 20, 2000Assignee: John Wayne Cancer InstituteInventors: Reiko F. Irie, Takanori Oka
-
Patent number: 6017739Abstract: A method for concentrating a mutant nucleic acid. In particular, the present method is capable of selectively separating and collecting a mutant nucleic acid from a sample including both the nucleic acid and the mutant nucleic acid. Also, an assay kit for nucleic acid concentration.Type: GrantFiled: March 13, 1998Date of Patent: January 25, 2000Assignee: Wakunga Seiyaku Kabushiki KaishaInventor: Takanori Oka
-
Patent number: 5948618Abstract: A nucleic acid differentiation method utilizing complementary strand-exchange reaction in competitive hybridization can clearly differentiate a site of gene mutation or a difference between genes in a target nucleic acid even when the gene mutation or difference is located near the primer binding site of the target nucleic acid.Type: GrantFiled: November 24, 1997Date of Patent: September 7, 1999Assignee: Wakunaga Seiyaku Kabushiki KaishaInventors: Takanori Oka, Akio Yamane